Which Type 2 Endoleaks Should We Intervene?

This work emphasizes the need to be conservative with type 2 endoleaks, and the need for long-term prospective information to learn about the advantages of intervention.

¿Qué endoleaks tipo 2 deben ser intervenidos?

The presence of type 2 endoleaks is associated with reintervention, as it was historically assumed that they increase the risk of sac rupture. However, this new research, published in Eur J Vasc Endovasc Surg, suggests that there are no differences in mortality after 10 years of follow-up among those who underwent a reintervention and those treated conservatively.

This retrospective cohort from several centers in the Netherlands included all patients who underwent endovascular repair of an infrarenal abdominal aortic aneurysm between 2007 and 2012.

The primary endpoint was survival of patients with type 2 endoleak vs. patients without endoleak. Secondary endpoints included sac growth, aneurysm rupture, and reintervention.

About 2018 patients were included, with a mean follow-up of >5 years and, in some cases, >10 years.

No differences were observed in terms of mortality between patients with and without endoleaks (n = 388 and n = 1630, respectively; p = 0.54). More importantly, among the 388 patients with endoleak, no differences were observed between patients who underwent reintervention and those treated conservatively


Read also: Un dolor de cabeza para los cardiólogos: Isquemia con enfermedad NO obstructiva.


Sac growth was detected in 89 patients with endoleak, which resulted in treatment for half the group only (n = 44, 49.8%).

In virtually all patients who received type 2 endoleak treatment for sac growth (n = 41, 93.1%), the sac continued to grow and was left without further intervention.

In 4 out of 388 patients with type 2 endoleak, the sac ruptured. According to the multivariate analysis, mortality predictors were age, surgical risk, and maximum iliac diameter. Endoleak presence, sac growth, and endoleak intervention did not predict mortality.

Conclusion

The long-term survival of patients with type 2 endoleak is similar to that of patients without it. Furthermore, no benefit was observed in reintervened patients vs. those treated conservatively. A prospective study is needed to define the prognosis of type 2 endoleaks and their need of intervention.

Original Title: Type 2 Endoleak With or Without Intervention and Survival After Endovascular Aneurysm Repair.

Reference: Sana Mulay et al. Eur J Vasc Endovasc Surg. 2021 May;61(5):779-786. doi: 10.1016/j.ejvs.2021.01.017.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...